Glutamine-induced protection of isolated rat heart from ischemia/reperfusion injury is mediated via the hexosamine biosynthesis pathway and increased protein O-GlcNAc levels

Journal of Molecular and Cellular Cardiology

Volumn 42, Issue 1, 2007, Pages 177-185

  Liu, Jia ^a   Marchase, Richard B ^a   Chatham, John C ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

Glutamine; Hexosamine biosynthesis; Ischemia reperfusion; Protein O GlcNAcylation

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALLOXAN; AZASERINE; BUFFER; ENZYME INHIBITOR; GLUCOSE; GLUTAMINE; GLUTAMINE FRUCTOSE 6 PHOSPHATE AMINOTRANSFERASE; HEXOSAMINE; N ACETYLGLUCOSAMINE; N ACETYLGLUCOSAMINYLTRANSFERASE; PROTEIN; TROPONIN I;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; CATALYSIS; CONTROLLED STUDY; ENZYME ANALYSIS; EX VIVO STUDY; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HEART MUSCLE ISCHEMIA; HEART PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; RAT; REPERFUSION INJURY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ACETYLGLUCOSAMINE; ADENOSINE TRIPHOSPHATE; ALLOXAN; ANIMALS; AZASERINE; CARDIOTONIC AGENTS; GLUTAMINE; GLYCOSYLATION; HEXOSAMINES; MALE; MYOCARDIAL REPERFUSION INJURY; N-ACETYLGLUCOSAMINYLTRANSFERASES; RATS; RATS, SPRAGUE-DAWLEY; URIDINE DIPHOSPHATE N-ACETYLGLUCOSAMINE;

EID: 33845632951     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2006.09.015     Document Type: Article

References (30)

1. Theroux P., Willerson J.T., and Armstrong P.W. Progress in the treatment of acute coronary syndromes: a 50-year perspective (1950-2000). Circulation 102 (2000) IV2-IV13
2. Heart Disease and Stroke Statistics: 2005 update: American Heart Association; 2005.
3. Khogali S.E., Harper A.A., Lyall J.A., and Rennie M.J. Effects of L-glutamine on post-ischaemic cardiac function: protection and rescue. J. Mol. Cell Cardiol. 30 (1998) 819-827
4. Khogali S.E., Pringle S.D., Weryk B.V., and Rennie M.J. Is glutamine beneficial in ischemic heart disease?. Nutrition 18 (2002) 123-126
5. Wischmeyer P.E., Jayakar D., Williams U., Singleton K.D., Riehm J., Bacha E.A., Jeevanandam V., Christians U., and Serkova N. Single dose of glutamine enhances myocardial tissue metabolism, glutathione content, and improves myocardial function after ischemia-reperfusion injury. J. Parenter. Enteral. Nutr. 27 (2003) 396-403
6. Liu J., Pang Y., Chang T., Bounelis P., Chatham J.C., and Marchase R.B. Increased hexosamine biosynthesis and protein O-GlcNAc levels associated with myocardial protection against calcium paradox and ischemia. J. Mol. Cell Cardiol. 40 (2006) 303-312
7. Zachara N.E., O'Donnell N., Cheung W.D., Mercer J.J., Marth J.D., and Hart G.W. Dynamic O-GlcNAc modification of nucleocytoplasmic proteins in response to stress. A survival response of mammalian cells. J. Biol. Chem. 279 (2004) 30133-30142
8. Wu G., Haynes T.E., Li H., Yan W., and Meininger C.J. Glutamine metabolism to glucosamine is necessary for glutamine inhibition of endothelial nitric oxide synthesis. J. Biochem. 353 (2001) 245-252
9. Love D.C., and Hanover J.A. The hexosamine signaling pathway: deciphering the "O-GlcNAc code". Sci. STKE 2005 (2005) re13
10. Pang Y., Bounelis P., Chatham J.C., and Marchase R.B. The hexosamine pathway is responsible for the inhibition by diabetes of phenylephrine-induced inotropy. Diabetes 53 (2004) 1074-1081
11. Comer F.I., Vosseller K., Wells L., Accavitti M.A., and Hart G.W. Characterization of a mouse monoclonal antibody specific for O-linked N-acetylglucosamine. Anal. Biochem. 293 (2001) 169-177
12. Robinson K.A., Weinstein M.L., Lindenmayer G.E., and Buse M.G. Effects of diabetes and hyperglycemia on the hexosamine synthesis pathway in rat muscle and liver. Diabetes 44 (1995) 1438-1446
13. Clark R.J., McDonough P.M., Swanson E., Trost S.U., Suzuki M., Fukuda M., and Dillmann W.H. Diabetes and the accompanying hyperglycemia impairs cardiomyocyte cycling through increased nuclear O-GlcNAcylation. J. Biol. Chem. 278 (2003) 44230-44237
14. Konrad R.J., Zhang F., Hale J.E., Knierman M.D., Becker G.W., and Kudlow J.E. Alloxan is an inhibitor of the enzyme O-linked N-acetylglucosamine transferase. Biochem. Biophys. Res. Commun. 293 (2002) 207-212
15. Wischmeyer P.E. Clinical applications of l-glutamine: past, present, and future. Nutr. Clin. Pract. 18 (2003) 377-385
16. Wischmeyer P.E., Vanden Hoek T.L., Li C., Shao Z., Ren H., Riehm J., and Becker L.B. Glutamine preserves cardiomyocyte viability and enhances recovery of contractile function after ischemia-reperfusion injury. J. Parenter. Enteral. Nutr. 27 (2003) 116-122
17. Singleton K.D., and Wischmeyer P.E. Oral glutamine enhances heat shock protein expression and improves survival following hyperthermia. Shock 25 (2006) 295-299
18. Yang S., Zou L., Bounelis P., Chaudry I.H., Chatham J.C., and Marchase R.B. Glucosamine administration during resuscitation improves organ function following trauma-hemorrhage. Shock 25 (2006) 600-607
19. Sohn K.C., Lee K.Y., Park J.E., and Do S.I. OGT functions as a catalytic chaperone under heat stress response: a unique defense role of OGT in hyperthermia. Biochem. Biophys. Res. Commun. 322 (2004) 1045-1051
20. Morrison A.L., Singleton K.D., Dinges M., Odoms K., Wong H.R., and Wischmeyer P.E. Glutamine's protection against cellular injury is dependent on heat shock factor-1. Am. J. Physiol. Cell Physiol. (2006)
21. Evans M.E., Jones D.P., and Ziegler T.R. Glutamine inhibits cytokine-induced apoptosis in human colonic epithelial cells via the pyrimidine pathway. Am. J. Physiol. Gastrointest. Liver Physiol. 289 (2005) G388-G396
22. Tiedge M., Richter T., and Lenzen S. Importance of cysteine residues for the stability and catalytic activity of human pancreatic beta cell glucokinase. Arch. Biochem. Biophys. 375 (2000) 251-260
23. Shafi R., Iyer S.P., Ellies L.G., O'Donnell N., Marek K.W., Chui D., Hart G.W., and Marth J.D. The O-GlcNAc transferase gene resides on the x chromosome and is essential for embryonic stem cell viability and mouse ontogeny. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 5735-5739
24. Wells L., Vosseller K., and Hart G.W. Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc. Science 291 (2001) 2376-2378
25. Hanover J.A. Glycan-dependent signaling: O-linked N-acetylglucosamine. FASEB J. 15 (2001) 1865-1876
26. Whelan S.A., and Hart G.W. Proteomic approaches to analyze the dynamic relationships between nucleocytoplasmic protein glycosylation and phosphorylation. Circ Res. 93 (2003) 1047-1058
27. Vosseller K., Sakabe K., Wells L., and Hart G.W. Diverse regulation of protein function by O-GlcNAc: a nuclear and cytoplasmic carbohydrate post-translational modification. Curr. Opin. Chem. Biol. 6 (2002) 851-857
28. Murphy E. Primary and secondary signaling pathways in early preconditioning that converge on the mitochondria to produce cardioprotection. Circ. Res. 94 (2004) 7-16
29. 2+ elevation in neonatal cardiomyocytes via protein-associated O-GlcNAc. Am. J. Physiol. Cell Physiol. 290 (2006) C57-C65
30. Hu Y., Belke D., Suarez J., Swanson E., Clark R., Hoshijima M., and Dillmann W.H. Adenovirus-mediated overexpression of O-GlcNAcase improves contractile function in the diabetic heart. Circ. Res. 96 (2005) 1006-1013